In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
Review top radiology content from the week.
Powered by artificial intelligence, the new Ultrasound Workspace platform reportedly offers advanced echocardiography capabilities and facilitates enhanced diagnostic workflows.
The expanded FDA clearance for Collaboration Live (Philips) gives clinicians the option to consult on or diagnose ultrasound images from their mobile devices.
In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.
In addition to newly added advances with hemodynamic assessment and obstetric measurements, Lumify also offers a B-line quantification tool and AI-enhanced algorithms that may bolster ultrasound lung imaging in severe COVID-19 cases.
Imaging test identifies patients most at risk for atrial fibrillation and atrial flutter.
Ultrasound tool, fueled by artificial intelligence software, works like a navigation system to help providers capture the best cardiac images.
For better cardiology services, providers must look beyond the existing cardiology PACS.
Here's what to expect this week on Diagnostic Imaging.
Using imaging to screen asymptomatic individuals can cause more potential harm than good, Task Force reiterates.
The pandemic’s impact on sonographers was largely a boomerang effect, but some struggles remain.
Left atrial diameter and fibrosis differences between African American and white patients could play a role the risk of ischemic stroke.
The radiologic technologists and sonographers have experienced changes during the viral outbreak.
Breast Cancer Screening in Indian & Pakistani Women; Fluciclovine PET for Prostate Cancer Imaging; Cardiac Ultrasound & COVID-19; and Improving Mammography Patient Experience
The modality is the only one that can be safely conducted at the bedside with patients on a ventilator.
New system incorporates artificial intelligence features intended to truncate exam time and create more consistently repeatable exams.
This clearance applies to lung and cardiac imaging in patients with viral infection.
Sonosite PX improve image quality and workflow at the patient’s bedside.
Monitoring color flow gain in 3D quantitative blood flow measurements provides accurate and reliable information.
